CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $36.43M, above the global median of $16.24M
- FinancialsAltman Z-Score 10.02: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.27%Above 5Y avg (0.88%)
Annual Rate
CNY 0.09Paid annual
Payout Ratio
28.9%Sustainable
Payback Period
76.9 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.88BCNY872.65M · vs all stocks (USD)
Trailing P/E
26.22xRevenue (TTM)
1.48BCNY218.92M · vs all stocks (USD)
Profit Margin
15.10%Beta
0.1230xvs all stocks
52-Week Change
-9.82%vs all stocks
Market Capitalization
5.88BCNY872.65M · vs all stocks (USD)
Enterprise Value
5.07BCNY751.16M · vs all stocks (USD)
Trailing P/E
26.22xForward P/E
20.82xPrice to Sales (TTM)
3.99xPrice to Book (MRQ)
2.07xEnterprise to Revenue
3.43xEnterprise to EBITDA
14.09xGross Margin
55.39%Profit Margin
15.10%Operating Margin
24.36%Return on Assets (TTM)
4.98%Return on Equity (TTM)
8.68%Revenue (TTM)
1.48BCNY218.92M · vs all stocks (USD)
Revenue per Share (TTM)
1.80CNYUpdated Aug 19, 2026Quarterly Revenue Growth
4.50%Gross Profit (TTM)
768.74MCNY114.00M · vs all stocks (USD)
EBITDA (TTM)
343.25MCNY50.90M · vs all stocks (USD)
Net Income (TTM)
222.94MCNY33.06M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.90%Operating Cash Flow (TTM)
315.72MCNY46.82M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
245.63MCNY36.43M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0900CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
1.27%vs all stocks
5-Year Average Dividend Yield
0.88%vs all stocks
Payout Ratio
28.86%Minority Interest (Equity)
396.50MCNYFY2025 · Dec 31, 2025Revenue
1.46BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
702.40MCNYFY2025 · Dec 31, 2025Gross Profit
757.56MCNYFY2025 · Dec 31, 2025Operating Income
284.36MCNY42.17M · vs all stocks (USD)
Pre-tax Income
303.61MCNYFY2025 · Dec 31, 2025Income Tax Expense
41.77MCNYFY2025 · Dec 31, 2025Net Income
261.84MCNYFY2025 · Dec 31, 2025EBIT
304.18MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
391.80MCNYFY2025 · Dec 31, 2025Research & Development
64.99MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
185.14MCNYFY2025 · Dec 31, 2025Other Operating Expenses
22.99MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
26.73MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
572.45KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2678CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2678CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
818.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
818.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
261.84MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-42.55MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
224.80MCNYFY2025 · Dec 31, 2025Free Cash Flow
204.53MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
848.81MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
261.84MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-7.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-13.20MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.39MCNYFY2025 · Dec 31, 2025Capital Expenditures
-20.28MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.60BCNYFY2025 · Dec 31, 2025Sale of Investments
1.28BCNYFY2025 · Dec 31, 2025Other Investing Activity
-130.38MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-469.59MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-10.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-65.24MCNYFY2025 · Dec 31, 2025Other Financing Charges
61.28MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-13.97MCNYFY2025 · Dec 31, 2025Shares Outstanding
829.67MSharesUpdated Aug 19, 2026Float Shares
515.25MSharesUpdated Aug 19, 2026% Held by Insiders
38.45%vs all stocks
% Held by Institutions
1.98%vs all stocks
Total Cash (MRQ)
1.24BCNY184.56M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.50CNYUpdated Aug 19, 2026Total Debt (MRQ)
5.52MCNY818.14K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0017xCurrent Ratio (MRQ)
5.54xBook Value per Share (MRQ)
3.41CNYUpdated Aug 19, 2026Total Assets
3.57BCNY529.48M · vs all stocks (USD)
Total Current Assets
2.03BCNYFY2025 · Dec 31, 2025Total Liabilities
421.13MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.54BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
26.34MCNYFY2025 · Dec 31, 2025Total Current Liabilities
394.79MCNYFY2025 · Dec 31, 2025Cash
850.99MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.93MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
854.92MCNYFY2025 · Dec 31, 2025Other Short-term Investments
434.74MCNYFY2025 · Dec 31, 2025Accounts Receivable
321.92MCNYFY2025 · Dec 31, 2025Inventory
277.32MCNYFY2025 · Dec 31, 2025Accounts Payable
155.40MCNYFY2025 · Dec 31, 2025Short-term Debt
2.10MCNYFY2025 · Dec 31, 2025Other Current Liabilities
16.88MCNYFY2025 · Dec 31, 2025Long-term Debt
1.68MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.31MCNYFY2025 · Dec 31, 2025Common Stock (Book)
829.67MCNYFY2025 · Dec 31, 2025Retained Earnings
1.01BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.15BCNY467.03M · vs all stocks (USD)
Treasury Stock
55.49MCNYFY2025 · Dec 31, 202552-Week Low
5.99CNYUpdated Aug 19, 202652-Week High
8.45CNYUpdated Aug 19, 202652-Week Change
-9.82%vs all stocks
Beta
0.1230xvs all stocks
50-Day MA
6.63CNYUpdated Aug 19, 2026200-Day MA
7.31CNYUpdated Aug 19, 2026Avg 10-Day Volume
15.79MSharesUpdated Aug 19, 2026Avg 30-Day Volume
13.89MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2700CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.02: safe zoneNotable
Altman Z-Score: 10.02
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $36.43M, above the global median of $16.24MNotable
Levered free cash flow (USD): 36,427,275.429Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Phathom Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kaibao Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Amphastar Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Oxford Biomedica plc
Tier 1ProductionApproval-Gated PipelineFlowRule
Sana Biotechnology, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Heilongjiang ZBD Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Theravance Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Warrants Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Boji Medical & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hpgc Renmintongtai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
National Healthcare Corporation
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Airtac International Group
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Nmdc Limited
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities